在早产新生儿中发病的富洛塞米德诱导的神经:对观察数据的批判性审查
John Dotis1, Alexandra Skarlatou2, Maria Fourikou1
1Third Department of Pediatrics, Aristotle University of Thessaloniki, Hippokration Hospital, 54642 Thessaloniki, Greece.
Children (Basel, Switzerland)
|November 27, 2025
概括
在早产婴儿中使用富罗塞米德与脏结症 (NC) 相关,这是一种脏问题. 证据表明剂量依赖的风险,但谨慎的管理可以减轻这种并发症.
科学领域:
- 新生儿医学 新生儿医学
- 儿科脏病学 儿科脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 富洛塞米德是早产新生儿的常见利尿剂.
- 甲 (NC) 是一种潜在的脏并发症,与furosemide相关.
- 西米德相关的NC的长期影响需要澄清.
研究的目的:
- 审查在早产婴儿中furosemide和NC之间的关联.
- 综合有关NC发生率,风险因素和结果的证据.
- 为了告知新生儿安全使用利尿剂.
主要方法:
- 对接受罗塞米德治疗的早产婴儿NC的观察性研究 (1982-2025) 的文献综述.
- 提取有关研究特征,NC流行率和富洛塞米德暴露的数据.
- 提取数据的描述性综合.
主要成果:
- 22项研究 (1489名婴儿) 显示NC的患病率在6-83%之间.
- 在怀孕32周以下的婴儿或1500克以下的婴儿中观察到更高的NC发生率.
- 在NC组中,累积的富罗塞米德剂量显著高于NC组 (10-19 mg/kg vs. ≤5 mg/kg),这表明了剂量与反应的关系.
- 在停止治疗后,NC解决发生在~60%的病例中.
- 最近的一项RCT表明,在谨慎使用罗西米德剂量 (≤2 mg/kg/天28天) 时,NC风险没有增加.
结论:
- 在早产婴儿中,furosemide和NC之间存在与剂量相关的关联.
- 谨慎的剂量和监测可能会减轻NC风险.
- 进一步的研究对于优化furosemide在新生儿中安全使用至关重要.
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Excretion
196
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
196
Acute Kidney Injury IV: Diagnostic Studies and Prevention
249
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
249
Urinary Tract Calculi I: Introduction
383
Renal calculi, or kidney stones, are solid deposits of minerals and salts formed inside the kidneys. In medical terminology, "calculus" refers to the stone itself, while "lithiasis" describes the process of stone formation. Depending on their location within the urinary system, these stones may be classified as either urolithiasis, when situated within the urinary tract, or nephrolithiasis, when located within the kidneys. Each term signifies the specific impact of the stone.Predisposition...
383
Acute Kidney Injury V: Interprofessional Care
284
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
284
Urinary Tract Calculi V: Nursing Management
259
AssessmentSubjective Data: Obtain a detailed health history, including any recent or chronic urinary tract infections, periods of immobilization, previous episodes of renal calculi, and medical conditions such as gout, benign prostatic hyperplasia, or hyperparathyroidism. Review the medication history for drugs that may influence stone formation, including allopurinol, analgesics, loop diuretics, or thiazide diuretics. Document the use of long-term indwelling catheters and any past surgical...
259
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
343
Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
343


